KMDA Q1 2019 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$495M

Q1 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$27M+53.6% YoY

Gross Profit

$11M41.7% margin

Operating Income

$5M19.4% margin

Net Income

$5M18.4% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

-44.4%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$6M

Stock-Based Comp.

$315,000

Balance Sheet

Total Assets

$145M

Total Liabilities

$28M

Stockholders' Equity

$117M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$27M	$17M	+53.6%
Gross Profit	$11M	$7M	+59.4%
Operating Income	$5M	$1M	+324.2%
Net Income	$5M	$1M	+292.0%